Celon Pharma SA (CLN) — Cash Flow Reinvestment Rate
Celon Pharma SA (CLN) has a Cash Flow Reinvestment Rate of 0.00x as of December 2025, reinvesting zł0.00 (capex zł0.00 ) from operating cash flow of zł36.63 Million. Check CLN cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Celon Pharma SA Cash Flow Reinvestment Rate (2012–2025)
Historical reinvestment intensity for Celon Pharma SA across 10 annual periods. Explore CLN operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Celon Pharma SA (2012–2025)
Year-by-year capital reinvestment analysis for Celon Pharma SA. For live market cap and broader valuation context, see Celon Pharma SA (CLN) market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (PLN) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.00x | zł0.00 | zł23.85 Million | zł0.00 | ▼ -100.0% |
| 2021 | 2.76x | zł121.22 Million | zł43.95 Million | zł41.35 Million | ▲ +35.2% |
| 2020 | 2.04x | zł144.60 Million | zł70.90 Million | zł99.16 Million | ▼ -14.6% |
| 2018 | 2.39x | zł67.47 Million | zł28.24 Million | zł67.46 Million | ▲ +92.8% |
| 2017 | 1.24x | zł31.35 Million | zł25.30 Million | zł31.34 Million | ▲ +20.2% |
| 2016 | 1.03x | zł21.29 Million | zł20.65 Million | zł21.29 Million | ▲ +20.4% |
| 2015 | 0.86x | zł44.86 Million | zł52.37 Million | zł44.86 Million | ▼ -7.5% |
| 2014 | 0.93x | zł22.55 Million | zł24.36 Million | zł22.55 Million | ▲ +38.6% |
| 2013 | 0.67x | zł5.64 Million | zł8.45 Million | zł5.64 Million | ▲ +97.8% |
| 2012 | 0.34x | zł4.34 Million | zł12.87 Million | zł4.34 Million | — |